Literature DB >> 17182727

Altered pH(i) regulation and Na(+)/HCO3(-) transporter activity in choroid plexus of cilia-defective Tg737(orpk) mutant mouse.

Boglarka Banizs1, Peter Komlosi, Mark O Bevensee, Erik M Schwiebert, Phillip D Bell, Bradley K Yoder.   

Abstract

Tg737(orpk) mice have defects in cilia assembly and develop hydrocephalus in the perinatal period of life. Hydrocephalus is progressive and is thought to be initiated by abnormal ion and water transport across the choroid plexus epithelium. The pathology is further aggravated by the slow and disorganized beating of motile cilia on ependymal cells that contribute to decreased cerebrospinal fluid movement through the ventricles. Previously, we demonstrated that the hydrocephalus phenotype is associated with a marked increase in intracellular cAMP levels in choroid plexus epithelium, which is known to have regulatory effects on ion and fluid movement in many secretory epithelia. To evaluate whether the hydrocephalus in Tg737(orpk) mutants is associated with defects in ion transport, we compared the steady-state pH(i) and Na(+)-dependent transport activities of isolated choroid plexus epithelium tissue from Tg737(orpk) mutant and wild-type mice. The data indicate that Tg737(orpk) mutant choroid plexus epithelium have lower pH(i) and higher Na(+)-dependent HCO(3)(-) transport activity compared with wild-type choroid plexus epithelium. In addition, wild-type choroid plexus epithelium could be converted to a mutant phenotype with regard to the activity of Na(+)-dependent HCO(3)(-) transport by addition of dibutyryl-cAMP and mutant choroid plexus epithelium toward the wild-type phenotype by inhibiting PKA activity with H-89. Together, these data suggest that cilia have an important role in regulating normal physiology of choroid plexus epithelium and that ciliary dysfunction in Tg737(orpk) mutants disrupts a signaling pathway leading to elevated intracellular cAMP levels and aberrant regulation of pH(i) and ion transport activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182727     DOI: 10.1152/ajpcell.00408.2006

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  21 in total

1.  Increased Na+/H+ exchanger activity on the apical surface of a cilium-deficient cortical collecting duct principal cell model of polycystic kidney disease.

Authors:  Dragos Olteanu; Xiaofen Liu; Wen Liu; Venus C Roper; Neeraj Sharma; Bradley K Yoder; Lisa M Satlin; Erik M Schwiebert; Mark O Bevensee
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-01       Impact factor: 4.249

Review 2.  Vasopressin and disruption of calcium signalling in polycystic kidney disease.

Authors:  Fouad T Chebib; Caroline R Sussman; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

3.  A mutation in Ccdc39 causes neonatal hydrocephalus with abnormal motile cilia development in mice.

Authors:  Zakia Abdelhamed; Shawn M Vuong; Lauren Hill; Crystal Shula; Andrew Timms; David Beier; Kenneth Campbell; Francesco T Mangano; Rolf W Stottmann; June Goto
Journal:  Development       Date:  2018-01-09       Impact factor: 6.868

Review 4.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

Review 5.  The Oak Ridge Polycystic Kidney mouse: modeling ciliopathies of mice and men.

Authors:  Jonathan M Lehman; Edward J Michaud; Trenton R Schoeb; Yesim Aydin-Son; Michael Miller; Bradley K Yoder
Journal:  Dev Dyn       Date:  2008-08       Impact factor: 3.780

Review 6.  Development and functions of the choroid plexus-cerebrospinal fluid system.

Authors:  Melody P Lun; Edwin S Monuki; Maria K Lehtinen
Journal:  Nat Rev Neurosci       Date:  2015-07-15       Impact factor: 34.870

Review 7.  Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

Review 8.  Treatment strategies and clinical trial design in ADPKD.

Authors:  Vicente E Torres
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

Review 9.  Novel therapeutic approaches to autosomal dominant polycystic kidney disease.

Authors:  Wells B LaRiviere; Maria V Irazabal; Vicente E Torres
Journal:  Transl Res       Date:  2014-11-13       Impact factor: 7.012

10.  A novel mouse model reveals that polycystin-1 deficiency in ependyma and choroid plexus results in dysfunctional cilia and hydrocephalus.

Authors:  Claas Wodarczyk; Isaline Rowe; Marco Chiaravalli; Monika Pema; Feng Qian; Alessandra Boletta
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.